Copyright: ©Author(s) 2026.
World J Methodol. Jun 20, 2026; 16(2): 114322
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.114322
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.114322
Table 2 Summary of representative studies reporting long-term stroke and vascular outcomes in women with a history of hypertensive disorders of pregnancy
| Ref. | Design/setting | Exposure/comparison | Sample (exposed/ref) | Follow-up (years) | Stroke outcome(s) | Effect (95%CI) | Notes |
| Verburgt et al[19], 2025 | Case-control, young women with ischemic stroke vs population controls | Any APO; HDP (PE/PIH) vs none | 358 stroke/714 ref | Up to prior pregnancies | Ischemic stroke | PE OR: 4.0 (2.4-6.8); HDP OR: 2.0 (1.4-2.7); SGA OR: 2.8 (2.0-3.9); Preterm OR: 2.7 (1.9-4.0) | HDP strongest with large-artery disease; suggests atherosclerotic mechanism in some cryptogenic strokes |
| Crump et al[20], 2025 | Nationwide cohort, Sweden | APOs (PTB, SGA, PE, other HTN, GDM) vs none | 35824 stroke/2201393 total | Up to 46 | All stroke | PE aHR: 1.36 (1.31-1.41); other HTN 1.82 (1.67-1.98); GDM 1.86 (1.69-2.04); PTB 1.40 (1.36-1.45); SGA 1.26 (1.22-1.29) | Risks persisted 30-46 years; partly explained by shared familial factors |
| Hung et al[21], 2022 | Nationwide cohort, Taiwan | HDP subtypes vs non-HDP | 13617 HDP/54468 ref | ≤ 17 | Any, ischemic, hemorrhagic | Any aHR: 1.71 (1.46-2.00); Isch aHR: 1.60 (1.35-1.89); Hem aHR: 2.98 (2.13-4.18) | Isch peak 1-3 years (aHR: 2.14); Hem peak 10-15 years (aHR: 4.64); highest with CH superimposed PE (aHR: 3.86) |
| Auger et al[36], 2020 | Provincial cohort, Canada | Very/moderate PTB vs term; mediation by maternal vascular disorders (including PE) | 1199364 | Approximately 10-20 | Ischemic stroke hospitalization | Incidence higher with PTB. For 95%CI PE explained 8.3% (very PTB) and 11.0% (moderate PTB) of PTB-stroke association | Specific stroke HRs by PTB reported; PE key mediator of PTB → stroke/CVD |
| Garovic et al[23], 2020 | Historical cohort, Olmsted County (United States) | Prior HDP vs matched referents | 571 HDP/1142 ref | Median 36 | Any stroke | HR: 2.27 (1.37-3.76) | HDP also increase CAD, CKD, arrhythmia; robust to adjustments |
| Arnott et al[24], 2020 | National registry, Australia | HDP (early-onset < 34 weeks) × smoking vs no HDP | 528106 (first births) | 10 (risk estimate) | Composite CVD (including ischemic stroke) | EO-HDP, non-smokers HR: 4.90 (3.00-7.80); EO-HDP + smoking HR: 23.5 (13.5-40.5) | Stroke included in composite; strong interaction with smoking |
| Gastrich et al[25], 2020 | Matched cohort, United States | History of PE vs matched controls | 6360 PE/325347 ref | Up to several years | Hospitalized stroke | HR: 1.81 (0.75-4.37) (NS) | MI and CV death increase; stroke directionally increase but underpowered |
| Kuo et al[26], 2018 | Nationwide cohort, Taiwan | PE/eclampsia vs age-matched controls | 1295 cases/5180 ref | Approximately 10 | Cerebrovascular disease (stroke) | Eclampsia HR: 10.71 (3.45-33.24); PE HR: 3.47 (1.46-8.23) | Hemorrhagic stroke: Eclampsia HR: 19.74; PE NS |
| Lobitz et al[27], 2024 | National admin cohort, Australia | Caesarean vs vaginal; adjusted including HDP/DM | 14179299 | ≤ 365 days PP | Stroke readmission | HR: 1.40 (1.26-1.56) | Increase 180-365 days (HR: 1.94) |
| Lin et al[29], 2016 | Nationwide cohort, Taiwan | PIH vs non-PIH | 28346 PIH/113384 ref | Approximately 10 | Intracranial hemorrhage | aHR: 2.81 (1.58-4.99) | Hemorrhagic risk increasing strongly |
| Nelander et al[30], 2016 | Cohort, Sweden (≥ 65 years) | Any HDP vs none | 3232 | To late life | Any stroke | HR: 1.36 (borderline) | Attenuated at oldest ages |
| Akhter et al[35], 2014 | Vascular imaging cohort, Norway | Severe PE vs normotensive | 42 PE/44 ref | 9 years (range 1-13) | Vascular surrogate (carotid IMT/plaques) | Intima 013 ± 0.02 mm vs 0.08 ± 0.01 mm (+63%); I/M ratio 0.27 ± 0.07 vs 0.15 ± 0.03 (+80%); IMT 063 ± 0.12 mm vs 0.61 ± 0.12 mm (+3%); media -7% | Increased carotid intimal thickening and arterial remodeling consistent with early subclinical atherosclerosis after severe PE |
- Citation: Hagood M, Lucke-Wold B. Long-term neurological consequences of hypertensive disorders of pregnancy: Implications for postpartum monitoring and intervention. World J Methodol 2026; 16(2): 114322
- URL: https://www.wjgnet.com/2222-0682/full/v16/i2/114322.htm
- DOI: https://dx.doi.org/10.5662/wjm.v16.i2.114322